Reported first quarter year-over-year revenue growth of 3.4% Company reiterates full-year 2026 guidance BEVERLY, Mass. — Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use …
Copyright © CB Herald. 2026
